Measure | Sex | COPD | Pneumoconiosis | Asthma | ILD and sarcoidosis | Other CRDs | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
2019 (95% UI) | % Change (1990–2019) | 2019 (95% UI) | % Change (1990–2019) | 2019 (95% UI) | % Change (1990–2019) | 2019 (95% UI) | % Change (1990–2019) | 2019 (95% UI) | % Change (1990–2019) | ||
ASIR | Female | 121.3 (113.9 to 128.9) | 26.8 (23.8 to 29.9) | 1.7 (1.3 to 2.1) | 70.3 (60.4 to 81.9) | 617.2 (506.8 to 752.3) | − 4.2 (− 9.2 to 0.2) | 342.0 (281.3 to 410.8) | 34.8 (30.2 to 39.2) | n/a | n/a |
Male | 179.3 (171.1 to 187.9) | 39.7 (36.3 to 43.3) | 0.2 (0.2 to 0.2) | − 32.8 (− 42.2 to − 21.5) | 564.3 (442.2 to 711.7) | − 3.5 (− 8.7 to 1.4) | 282.7 (232.7 to 333.8) | 39.8 (34.8 to 45.2) | n/a | n/a | |
ASPR | Female | 1981.2 (1876.6 to 2093.3) | 23.4 (20.8 to 26.1) | 4.1 (3.2 to 5.1) | 82.9 (69.7 to 101.1) | 4150.0 (3605.6 to 4833.4) | − 8.3 (− 12.7 to − 4.0) | 49.5 (42.4 to 57.0) | 39.5 (35.1 to 43.9) | n/a | n/a |
Male | 2681.6 (2575.5 to 2793.8) | 36.0 (33.2 to 39.3) | 1.1 (1.0 to 1.4) | − 32.8 (− 42.2 to − 21.5) | 3508.7 (2933.2 to 4244.6) | − 7.1 (− 12.0 to − 1.6) | 39.9 (34.3 to 46.1) | 45.1 (39.9 to 50.3) | n/a | n/a | |
ASDR | Female | 19.5 (14.7 to 22.6) | − 18.2 (− 35.4 to 28.7) | 0 (0 to 0) | 56.9 (14.7 to 119.9) | 8.2 (6.5 to 10.1) | − 57.2 (− 70.7 to − 45.3) | 1.2 (0.8 to 2.2) | 2.9 (− 20.4 to 54.1) | 0.3 (0.2 to 0.4) | 2.8 (− 39.7 to 66.8) |
Male | 32.6 (27.5 to 37.1) | − 18.9 (− 34.3 to 0.3) | 0.1 (0.1 to 0.1) | − 27.5 (− 49.0 to 34.2) | 8.6 (6.9 to 10.9) | − 60.6 (− 68.1 to − 46.9) | 1.3 (0.9 to 2.2) | 6.0 (− 20.5 to 92.3) | 0.4 (0.2 to 0.5) | 18.0 (− 33.2 to 111.3) | |
Age-standardized DALYs | Female | 509.1 (430.2 to 569.2) | − 12.3 (− 25.0 to 23.4) | 1.4 (1.1 to 1.8) | 70.3 (43.2 to 108.6) | 331.6 (263 to 418.6) | − 45.4 (− 57.1 to − 34.6) | 29.6 (21.2 to 51.2) | 9.1 (− 13.5 to 47.0) | 28 (23.5 to 32.8) | 42.6 (− 2.1 to 81.6) |
Male | 786.2 (686.7 to 883) | − 12.0 (− 25.4 to 3.1) | 2.6 (2.1 to 3.1) | − 35.3 (− 54.1 to 9.6) | 317.5 (248.8 to 394.4) | − 49.5 (− 57.4 to − 37.6) | 30.5 (23.4 to 46.7) | 10.4 (− 17.9 to 74.8) | 28.4 (23.1 to 33.5) | 42.5 (− 2.3 to 89.1) | |
Age-standardized YLLs | Female | 313.4 (239.3 to 366.1) | − 25.5 (− 39.5 to 24.3) | 0.8 (0.6 to 1.0) | 64.5 (23.5 to 132.6) | 171.5 (135.6 to 216.1) | − 60.4 (− 71.4 to − 49.8) | 24.5 (16.6 to 46.2) | 4.9 (− 18.8 to 51.2) | 9.1 (6.1 to 12.7) | − 11.7 (− 49.9 to 49.5) |
Male | 558.3 (462.5 to 644.6) | − 22.9 (− 38.0 to − 6.0) | 2.4 (1.9 to 2.9) | − 37.5 (− 56.4 to 8.9) | 179.7 (142.1 to 230.1) | − 62.6 (− 69 to − 50.4) | 26.3 (19.4 to 42.3) | 6.9 (− 22.0 to 80.8) | 12.3 (8.1 to 16.0) | 1.9 (− 41.4 to 71.8) | |
Age-standardized YLDs | Female | 195.7 (160.8 to 222.7) | 22.3 (19.0 to 25.7) | 0.6 (0.4 to 0.9) | 78.0 (63.2 to 96.3) | 160.1 (104.3 to 236.1) | − 8.2 (− 12.7 to − 3.5) | 5.1 (3.4 to 7.5) | 35.4 (26.0 to 45.6) | 18.9 (15.2 to 22.2) | 102.8 (92.2 to 113.4) |
Male | 227.8 (183.1 to 266.7) | 34.8 (31.1 to 38.4) | 0.2 (0.1 to 0.3) | 21.8 (7.9 to 36.4) | 137.8 (87.7 to 205.1) | − 6.8 (− 11.9 to − 1.1) | 4.2 (2.8 to 6.2) | 39.3 (30.2 to 50.3) | 16.1 (12.6 to 19.7) | 105.2 (94.8 to 115.9) |